SAM
ALDR
Senzar Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-85,558
| Closed | -$1.35M | – | 23 |
|
|
2018
Q2 | $1.35M | Sell |
85,558
-737,332
| -90% | -$11.7M | 3.9% | 11 |
|
|
2018
Q1 | $10.5M | Buy |
822,890
+36,020
| +5% | +$457K | 3.3% | 10 |
|
|
2017
Q4 | $9.01M | Buy |
786,870
+145,700
| +23% | +$1.67M | 2.3% | 17 |
|
|
2017
Q3 | $7.85M | Buy |
641,170
+83,400
| +15% | +$1.02M | 1.92% | 15 |
|
|
2017
Q2 | $6.39M | Buy |
557,770
+342,700
| +159% | +$3.92M | 1.57% | 16 |
|
|
2017
Q1 | $4.47M | Buy |
215,070
+90,500
| +73% | +$1.88M | 1.13% | 23 |
|
|
2016
Q4 | $2.59M | Sell |
124,570
-172,100
| -58% | -$3.58M | 0.69% | 25 |
|
|
2016
Q3 | $9.72M | Sell |
296,670
-42,400
| -13% | -$1.39M | 2.51% | 16 |
|
|
2016
Q2 | $8.47M | Sell |
339,070
-174,500
| -34% | -$4.36M | 1.84% | 18 |
|
|
2016
Q1 | $12.6M | Sell |
513,570
-43,600
| -8% | -$1.07M | 2.5% | 13 |
|
|
2015
Q4 | $18.4M | Buy |
557,170
+7,270
| +1% | +$240K | 2.05% | 16 |
|
|
2015
Q3 | $18M | Buy |
+549,900
| New | +$18M | 2.62% | 13 |
|